Researchers have developed a technique that involves gluing two proteins together to encourage cancer cells to self-destruct. This innovative approach, known as “protein degradation,” uses a type of molecule called a PROTAC (proteolysis-targeting chimeras) to bind a disease-causing protein to another protein that tags it for destruction.
Essentially, it reprograms the cell’s machinery to remove harmful proteins selectively, triggering cancer cells to destroy themselves while sparing healthy cells. This technique is still being refined, but it represents a promising strategy for targeted cancer therapy, especially for cancers resistant to conventional treatments. 📸- Ella Maru Studio/ Stanford Medicene
Essentially, it reprograms the cell’s machinery to remove harmful proteins selectively, triggering cancer cells to destroy themselves while sparing healthy cells. This technique is still being refined, but it represents a promising strategy for targeted cancer therapy, especially for cancers resistant to conventional treatments. 📸- Ella Maru Studio/ Stanford Medicene